A Study to Compare Insulin Pump With Conventional Treatment in Type 2 Diabetes
Status:
Unknown status
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Insulin deficiency resulted from progressive beta cell failure and insulin resistance in type
2 diabetes requires exogenous insulin therapy, escaping from oral antihyperglycemic agents.
Previous data have been suggested that continuous subcutaneous insulin infusion (CSII) does
not only have efficacy in glucose control but also restore beta cell failure.
The investigators plan to compare the efficacy/safety and beta cell function between insulin
pump treatment and the intensification of conventional treatment in patients with
uncontrolled type 2 diabetes.